Dexmedetomidine: a safe alternative to general anesthesia for endovascular stroke treatment
Authors:
- 12 June 2013
- journal article
- research article
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 6 (4) , 270-275
Abstract
Background and purpose: There have been reports that general anesthesia (GA) is associated with worse clinical outcomes during intra-arterial treatment (IAT) for stroke. Since traditional sedatives carry the risk of respiratory depression, this retrospective study was designed to compare sedation with the α2 adrenergic agonist dexmedetomidine (DEX) and with GA for IAT procedures. Methods: We reviewed our institutional endovascular database of 216 consecutive patients who received DEX or GA for IAT of anterior circulation strokes between September 2010 and July 2012. The demographic, radiographic and angiographic variables between the GA and DEX groups were compared, as well as hemodynamic changes during the procedure. Binary logistic regression models were generated to determine the independent predictors of a favorable outcome (defined as a modified Rankin Score at 90 days of 0–2). Results: 83 patients had IAT performed under DEX sedation. Their demographic characteristics were similar to those given GA except that they were older and had less severe strokes. The GA group experienced greater variations in blood pressure, more hypotension with induction (54% vs 28%, p<0.001) and greater use of vasopressors (79% vs 58%, p<0.001). In our regression models, independent predictors of a good outcome included age, NIH Stroke Scale (NIHSS) score, Alberta Stroke Program Early CT score (ASPECTS), successful reperfusion, lower baseline systolic blood pressure and higher blood pressures during the procedure. DEX was associated with a good outcome when models included NIHSS as the sole measure of stroke severity but was equivalent to GA when ASPECTS was added to the analysis. Conclusions: DEX can be safely administered in patients undergoing endovascular reperfusion therapies. Further study is required to determine if outcomes are different among sedatives used during such procedures.Keywords
This publication has 18 references indexed in Scilit:
- Anesthetic Management and Outcome in Patients during Endovascular Therapy for Acute StrokeAnesthesiology, 2012
- Conscious Sedation Versus General Anesthesia During Endovascular Therapy for Acute Anterior Circulation StrokeStroke, 2010
- Comparison of Safety and Clinical and Radiographic Outcomes in Endovascular Acute Stroke Therapy for Proximal Middle Cerebral Artery Occlusion With Intubation and General Anesthesia Versus the Nonintubated StateStroke, 2010
- Dexmedetomidine vs Midazolam for Sedation of Critically Ill PatientsA Randomized TrialJAMA, 2009
- Effect of Sedation With Dexmedetomidine vs Lorazepam on Acute Brain Dysfunction in Mechanically Ventilated PatientsJAMA, 2007
- Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated PneumoniaAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Dexmedetomidine and Neurocognitive Testing in Awake CraniotomyJournal of Neurosurgical Anesthesiology, 2004
- ICU sedation after coronary artery bypass graft surgery: dexmedetomidine-based versus propofol-based sedation regimensJournal of Cardiothoracic and Vascular Anesthesia, 2003
- Trial Design and Reporting Standards for Intraarterial Cerebral Thrombolysis for Acute Ischemic StrokeJournal of Vascular and Interventional Radiology, 2003
- Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapyThe Lancet, 2000